„We are very happy to be here in Ukraine. Positive changes in clinical trial regulations and healthcare reforms conducted in Ukraine in recent years have been noticed by the industry. We can observe the growing number of experienced and motivated investigators and increasing awareness of clinical research among patients. Our mission is to improve patients’ access to clinical research and it is not an accident that Ukraine is one of the first CEE destinations of Pratia international expansion.” – says Lukasz Bęczkowski VP of Pratia.
„As for today, in Ukraine, we have the ability to support our Clients in multiple therapeutics areas including among others vaccinations, oncology, dermatology, pulmonology, infectious and cardiovascular diseases, general medicine. We plan to significantly grow our capabilities with the opening Pratia Dedicated Clinical Research Site & Oncology Unit in Kharkiv by Q1 2021.” – says Anna Titkova, Pratia Ukraine Director of Operations.
Pratia Site Network offers to the pharmaceutical industry more than 20 research sites across Europe. Partia’s more than 250 experienced and highly qualified Principal Investigators enable access to a wide portfolio of therapeutic areas in both hospital and ambulatory setup including oncology.